|
Volumn 345, Issue , 2012, Pages
|
Germany opposes EU plans for regulating clinical trials owing to lack of ethical standards.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CLINICAL TRIAL (TOPIC);
DRUG APPROVAL;
DRUG INDUSTRY;
ETHICS;
EUROPEAN UNION;
GERMANY;
HEALTH CARE QUALITY;
HUMAN;
LEADERSHIP;
LEGAL ASPECT;
MEDICAL ETHICS;
METHODOLOGY;
MULTICENTER STUDY (TOPIC);
NOTE;
PATIENT SAFETY;
PROFESSIONAL STANDARD;
PUBLIC HEALTH;
SOCIAL CONTROL;
STANDARD;
CLINICAL TRIALS AS TOPIC;
CODES OF ETHICS;
DRUG APPROVAL;
DRUG INDUSTRY;
ETHICS COMMITTEES;
ETHICS, MEDICAL;
EUROPEAN UNION;
GERMANY;
HUMANS;
LEADERSHIP;
MULTICENTER STUDIES AS TOPIC;
NATIONAL HEALTH PROGRAMS;
PATIENT SAFETY;
QUALITY ASSURANCE, HEALTH CARE;
RESEARCH DESIGN;
SOCIAL CONTROL, FORMAL;
MLCS;
MLOWN;
|
EID: 84871893197
PISSN: None
EISSN: 17561833
Source Type: Journal
DOI: 10.1136/bmj.e6640 Document Type: Note |
Times cited : (2)
|
References (0)
|